Market Size
Global Patient Registry Software Market size was valued at US$ 2.68 Billion in 2025, growing at a CAGR of 9.2% during the forecast period (2026-2033).
The patient registry software market is growing with the rising burden of chronic non-communicable diseases like heart disease, cancer, diabetes, and stroke, which the WHO says account for about 74% of all deaths globally. These diseases are not only a health crisis but also a massive economic challenge, with the NIH estimating they could cost the global economy US$47 trillion by 2030. This condition has created a strong need for patient registry software, which helps hospitals and researchers track patient outcomes, manage cohorts, and support public health planning more effectively.
Advances in technology are driving further growth, particularly the integration of AI, cloud computing, and interoperable health data systems. In October 2025, John Snow Labs introduced a platform that fully automates oncology patient registries using multimodal AI, agentic workflows, and human oversight. This innovation addresses the challenge of extracting structured data from thousands of pages of pathology, radiology, genomics, and clinical notes, reducing the complexity and errors of manual abstraction.
With rising chronic diseases and breakthroughs like AI-driven automation, the patient registry software market is growing fast, helping healthcare systems track patients, generate insights, reduce costs, and improve care worldwide.
Patient Registry Software Market Summary
| Metrics | Details |
| Market CAGR | 9.2% |
| Segments Covered | By Disease Registry Type, By Functionality Type, By End-User, and By Region |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
| Fastest Growing Region | Asia Pacific |
| Largest Market Share | North America |
To Get a Free Sample Click here
Market Dynamics
The patient registry software market growth is driven by government initiatives, the rising adoption of patient registry softwares for the diagnosis of disease, increase and research and development activities.
The acceptance of Electronic Health Records (EHR) is expected to drive the market growth
In the digital world, information communication technologies are commonly used and extensive in the healthcare industry to handle big data and ample health information. According to the International Organization for Standardization (ISO), EHR is considered a repository of patient data in digital form, stored and exchanged securely and accessible by multiple authorized users. Adopting this system in the healthcare sector has several advantages, such as improving patient care, minimizing cost, increasing revenue, reducing medical errors, reducing the need for file space, data confidentiality, central patient data management, and sharing medical information. In addition, the EHR enables clinicians to easily analyze patient data to discover new treatments, uncover safety issues, and identify unusual clinical findings.
In addition, the market players are adopting different market strategies, including product launches and collaboration.
The high cost of Patient Registry Software will hamper the growth of the market
However, more than 50% of electronic record projects worldwide failed without providing their targeted benefits. Especially the implementation of EHR remains a major challenge in the healthcare sector in low-income countries such as Sub-Saharan countries. Merely 15% of low-income countries have nationally adopted electronic record systems in health institutions.
Market Segment Analysis
The Point Of Care (POC) segment is expected to grow at the fastest CAGR during the forecast period (2026-2033).
The Point Of Care (POC) segment is expected to boost the market over the forecast period. This promotes accessibility of POC results, the ability to monitor and trend, prevents unnecessary repeat testing and provides evidence for patient outcomes. As POC results are used to make clinical decisions, it is important to document results with associated reference intervals, units of measurement, critical values if applicable, date and time of testing, and also be traceable to device serial number, operator identification number, reagent lot number, and quality control (QC) results. POC results should also be differentiated from other central laboratory results to avoid confusion and trending results from different analytical methodologies. POC is routine in all hospitals and has become the standard for patient care in various healthcare settings.
Key Developments
March 2026: IQVIA launched an advanced AI-integrated patient registry platform, featuring real-time data analytics and predictive modeling for chronic disease tracking.
January 2026: Cerner Corporation introduced Evident, a cloud-native patient registry software with blockchain-secured data sharing for multi-site clinical studies.
November 2025: Oracle Health unveiled registry enhancements within its AI-powered EHR suite, focusing on voice-activated data entry and automated compliance reporting.
Market Geographical Analysis
North America region holds the largest market share of the global patient registry software market
North America dominates the market for Patient Registry Software and is expected to show a similar trend over the forecast period. It is estimated to hold a significant market size over the forecast period (2026-2033) owing to increasing government support for the development, advanced healthcare infrastructure, and point-of-care management. The development of digital infrastructure in the healthcare sector and the adoption of technological advancements by healthcare professionals and staff drive the market in the North American region.
In addition, the market players are adopting product launches and collaboration strategies to expand their business in the North American region.
Market Competitive Landscape
The patient registry software market is a moderately competitive presence of local and global companies. Some of the key players contributing to the market's growth are Dacima Software Inc., McKesson Corporation, Global Vision Technologies Inc., ImageTrend Inc., Liaison Technologies, Optum Inc., Phytel Inc., and Quintiles IMS Holdings Inc., among others. The major players are adopting several growth strategies, such as product launches, acquisitions, and collaborations, contributing to the growth of the global patient registry software market.
Dacima Software Inc
Overview:
Dacima Software is a flexible company founded in 2003 and has developed advanced clinical software that helps solve the business's major strategic and operational challenges.
Product Portfolio:
DACIMA REGISTRY: The Dacima REGISTRY is a modified database creation software that permits users to produce registries and administrative databases without expertise in computer programming or database design theory.
The global Patient Registry Software market report would provide access to approximately 65+ market data tables, 65+ figures, and in the range of 200+ (approximate) pages.
